000 06055nam a2200457 i 4500
999 _c393932
_d393932
001 393932
003 ES-MaUEC
005 20230102123037.0
006 a||||fo|||| 00| 0
007 cr nn 008mamaa
008 220908s2022 sz a o |||| 0|eng d
020 _a9783031080456
024 7 _a10.1007/978-3-031-08045-6
_2doi
040 _aES-MaUEC
_bspa
_cES-MaUEC
_dES-MaUEC
050 4 _aRA644.C67
_b2022 EB
245 0 0 _aFrontiers of COVID-19 :
_bScientific and Clinical Aspects of the Novel Coronavirus 2019
_cedited by Sasan Adibi, Paul Griffin, Melvin Sanicas, Maryam Rashidi, Francesco Lanfranchi
250 _a1st edition 2022
264 1 _aCham
_bSpringer International Publishing
_c2022
300 _a1 recurso en línea (XX, 664 páginas)
_b126 ilustraciones, 93 ilustraciones a color
336 _atexto
_btxt
_2rdacontent
337 _aelectrónico
_bc
_2rdamedia
338 _arecurso electrónico
_bcr
_2rdacarrier
347 _aarchivo de texto
_bPDF
505 0 _aSection I. History, Epidemiologic Background and Pathogenesis of Coronavirus -- Chapter 01: Surfaces as a source for SARS-CoV-2 transmission -- Chapter 02: Humoral immune response in SARS-CoV-2 infection & its therapeutic relevance -- Chapter 03: SARS-CoV-2 Invasion and Pathogenesis of COVID-19: A Perspective of viral receptors, bradykinin and purinergic system -- Chapter 04: Genetics and Biological characteristics of SARS-CoV-2 -- Chapter 05: COVID-19 impact on host at pathophysiological and cellular level -- Chapter 06: Identification of the COVID-19 droplet deposition path and its effects on the human respiratory tract before and after the disease: A scoping novel respiratory mask design -- Chapter 07: SARS-CoV-2 variants: Impact of Spike Mutations on Vaccine and Therapeutic strategies -- Chapter 08: Global biologic characteristics of Variants of Concern and Variants of Interest of SARS-CoV-2 -- Chapter 09: Emergence of COVID-19 variants and its global impact -- Section II. Clinical Observations -- Chapter 10: Psychological Impacts of the COVID-19 Pandemic -- Chapter 11: Spatial Epidemiology of COVID-19: Disease Risk, Prognosis, and Complications -- Chapter 12: Eye disorders and neuro-ophthalmic manifestations of COVID-19 -- Chapter 13: Evaluation and Management of Dysphagia during the COVID-19 Pandemic -- Chapter 14: Gastrointestinal Manifestations Of COVID-19, and Inflammatory Bowel Disease in the COVID-19 Era, Clinical Overview And Updated Guidelines -- Chapter 15: Post COVID-19 conditions-the new challenge to mankind -- Chapter 16: Association of Alpha 1 Antitrypsin deficiency with COVID-19 mortality: basis for clinical trials -- Chapter 17: Social cognition approaches to understanding and changing COVID-19 preventive behaviours -- Chapter 18: Neurological Complications of COVID-19 -- Chapter 19: The Impact of Covid-19 on Surgical Disease -- Section III. Interventions and Treatments -- Chapter 20: Pre-Hospital Management of COVID-19: Looking for a Future Perspective -- Chapter 21: Biotechnological strategies in the intervention and treatment of COVID-19 -- Chapter 22: Vitamin D: A Potential Prophylactic and Therapeutic Agent against COVID-19 -- Section IV. Current Trends and Future Directions -- Chapter 23: Rational repurposing of drugs, clinical trials candidates, and natural products for SARS-Cov-2 therapy -- Chapter 24: In Silico Drug Repositioning for COVID-19: Progress and Challenges -- Chapter 25: Computationally Repurposed Natural Products Targeting SARS-CoV-2 Attachment and Entry Mechanisms -- Chapter 26: Different platforms, immune response modulators and challenges in SARS-CoV-2 vaccination -- Chapter 27: SARS-CoV-2 vaccine against virus: mission accomplished !? -- Chapter 28: COVID-19 vaccines authorized by stringent regulatory authorities and vaccine candidates expecting approval in 2021 -- Chapter 29: The Global Evolution of Clinical Practice During a Pandemic -- Chapter 30: Anticipated Long-Term Neurobehavioral Outcomes following COVID-19 -- Chapter 31. The road ahead.
520 _aThis book aims to serve the critical interests of the global community by supplying the most current knowledge and understanding of Covid-19 epidemiology, treatment, and prognoses. There was much uncertain and contradictory information published in the first year of the novel coronavirus. The dynamics of COVID-19 have now been realized, including the type of antibodies produced in infected patients and their limited lasting endurance. This book will set the record straight on the concept of "herd immunity" and explore the current vaccine trials taking place in different countries. This comprehensive book will illuminate recent advances regarding COVID-19 and offer a possible roadmap on how to move forward. Frontiers of COVID-19: A Pathophysiology and Epidemiology Roadmap of Novel Coronavirus Disease will be a vital and forward-looking guide for infectious disease clinicians, scientists and researchers, and students at the graduate level.
988 _aSpringer_Medicine_2022
650 7 _2embne
_9683668
_aCOVID-19
700 1 _aAdibi, Sasan
_eeditor literario
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
700 1 _aGriffin, Paul
_eeditor literario
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
700 1 _aSanicas, Melvin
_eeditor literario
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
700 1 _aRashidi, Maryam
_eeditor literario
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
700 1 _aLanfranchi, Francesco
_eeditor literario
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
776 0 8 _iPrinted edition:
_z9783031080449
776 0 8 _iPrinted edition:
_z9783031080463
776 0 8 _iPrinted edition:
_z9783031080470
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-031-08045-6
_zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942 _2lcc
_cLE
998 _b12/2022
_dz
_eb
_zSI